
US Health secretary Kennedy revives misleading claims of 'fetal debris' in measles shots
Washington: U.S. health secretary
Robert F. Kennedy Jr.
reprised various misleading claims about vaccines this week, including that the
measles vaccine
contains cells from aborted fetuses and the mumps vaccination does not work.
Kennedy's comments come as the U.S. battles one of its worst outbreaks of measles in 25 years. Scientists have warned that the U.S. is at a tipping point for the return of endemic measles, declared eradicated nationally in 2000, and say U.S.
public health officials
like Kennedy should provide urgent endorsement for highly effective vaccines.
Two children have died and hundreds more have been infected in the outbreak in Texas, which is centered in a Mennonite community and has spread to neighboring states, including New Mexico, Oklahoma, and Kansas.
Kennedy says he is not opposed to vaccines, but has begun to revive some of the unproven or debunked theories he promoted as a lawyer and public figure, now from his perch at the U.S. Health and Human Services Department.
"There are populations in our country, like the Mennonites in Texas, (who) were most afflicted, and they have religious objections to the vaccination, because the MMR vaccine contains a lot of aborted fetus debris and DNA particles, so they don't want to take it," he said in a News Nation interview on Wednesday.
Kennedy was referring to the combined Measles, Mumps and Rubella vaccine. The vaccines do not contain "fetal debris" from abortions or intact fetal cells, vaccine experts said.
The rubella portion of the vaccine is produced from a fetal cell line originating from an abortion that took place in the 1960s. The MMR vaccine does not contain the cells in its final form.
The cells are derived from fetal cells that have been replicated over decades in test tubes in laboratory settings, thousands of times removed from the original ones.
"The virus is grown in these cells, then this virus is purified, meaning everything other than the virus is filtered out, and all that's left is this attenuated virus that can't make you sick," said Dr. Miriam Laufer, Interim Director of the Center for Vaccine Development and Global Health at the University of Maryland.
According to a fact sheet on how vaccines are made from the Children's Hospital of Philadelphia at the University of Pennsylvania, the amount of DNA involved in final vaccine preparation is minimal; billionths or trillionths of a gram.
"While the final vaccines do not contain intact fetal cells, they may contain trace amounts of cell-derived materials, such as fragments of DNA," said Dr. Paulo Verardi, Professor of Virology and Vaccinology and the University of Connecticut.
The Department of Health and Human Services did not respond to a request for comment.
Kennedy also said this week that the mumps portion of the vaccine does not work and that there were safety concerns over it.
"The problem is really with the mumps portion of the vaccine and the combination. That combination was never safety tested," he said on Monday at a live televised town hall event hosted by TV host Dr. Phil.
Two doses of the MMR vaccine provide around 86% protection against mumps, according to the U.S. Centers for Disease Control and Prevention.
While it is true that vaccine protection can wane over time, the rate varies depending on the disease and vaccine, Verardi and other vaccine experts said.
"For mumps in particular, immunity can decline, so adults vaccinated in childhood may become susceptible again. Still, vaccinated individuals generally experience a milder illness if infected, which is still a key benefit of vaccination," he said.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Time of India
2 days ago
- Time of India
Canada measles crisis: Alberta in panic over worst outbreak in 45 years, memories of pre-vaccine times back
Alberta is facing a severe measles outbreak, with 868 confirmed cases since March 2025, levels unseen since 1979. Northern Alberta communities are under exposure advisories due to low vaccination rates. Health officials are urging immediate vaccination, including early MMR doses for infants in high-risk areas, to combat the resurgence of this highly contagious disease. Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads Early MMR dose FAQs Tired of too many ads? Remove Ads High fever (often > 38.5°C / 101°F) Cough Runny nose Red, watery eyes (conjunctivitis) Tiny white spots inside the mouth (Koplik spots) A red rash that typically starts on the face and spreads downward Alberta is in the grip of its worst measles outbreak in nearly half a century, with 868 confirmed cases since March 2025. These levels of infection haven't been seen in the province since 1979, and alarmingly, provincial officials warn that more cases are likely outbreak has haunted communities into renewed vigilance. In northern Alberta, standing exposure advisories now cover La Crête, Fort Vermilion, and High Level, areas where low vaccination rates have allowed the virus to to the Alberta government, the highest recorded measles case count was in 1957, when 12,337 cases were Canada lost its 'measles elimination' status in 1998, but this massive surge reminds us how fragile that milestone can Craig Jenne at the University of Calgary describes the spike as alarming: 'We're really going back to pre-vaccination times here in Alberta,' a return to the era before the MMR vaccine was introduced in the 879 reported cases (as of June 13), 251 involve children under five and 407 involve school-age kids. Among those infected, 690 were entirely unvaccinated, and only 38 had received two MMR doses. Seventy-five people have been hospitalized, and 12 required intensive alerts have a broad reach, extending from Canmore and Banff to Calgary, layered on top of standing advisories in rural zonesPublic health experts stress immediate vaccination as the only clear defense. Alberta Health now offers an early MMR dose to infants starting at six months in high-risk areas , along with rapid post-exposure immunity options for recent measles once declared eliminated in Canada, this resurgence fuels discomfort, bringing back painful images of past is a highly contagious viral infection caused by the measles virus. It spreads easily through airborne droplets when an infected person coughs or sneezes. It can linger in the air for up to 2 hours after can be dangerous, especially for young children, pregnant people, and those with weakened immune usually appear 7 to 14 days after exposure and may include:Complications can include pneumonia, brain swelling (encephalitis), and even MMR vaccine (Measles, Mumps, and Rubella) is the best protection. Two doses offer about 97 percent immunity. In high-risk areas, babies as young as 6 months can receive an early dose. Post-exposure vaccines or immune globulin may help prevent illness if given within 72 hours of contact.

The Hindu
2 days ago
- The Hindu
Novavax's COVID-flu combo vaccine shows strong immune response in trial
Novavax's experimental COVID-19-influenza combination and standalone influenza vaccines generated a strong immune response in adults aged 65 and older, similar to already approved shots against the viruses in a late-stage trial. Both the vaccine candidates were well tolerated with no new safety concerns, the biotech said on 11 June 2025. . Its shares rose 1.3% to $7.29 in premarket trading. The study, which involved about 2,000 participants, tested the safety and immune response of the COVID-influenza combination and standalone flu vaccines compared to its COVID-19 shot Nuvaxovid and Sanofi's flu shot Fluzone HD, respectively. Novavax said the study was not designed to show statistically significant results. The data will be used to design a future late-stage study, which can be submitted for regulatory approval, it said. The Maryland-based biotech, which is shifting its focus to commercialising its candidates through partnerships, said it continues to look for partners that can advance further development of these experimental vaccines. It had signed a licensing deal with Sanofi worth up to $1.2 billion last year to commercialize and further develop its COVID-19 vaccine, Nuvaxovid. Nuvaxovid gained the U.S. approval last month after the Food and Drug Administration missed an April 1 target to approve the shot. The approval, however, limited its use to older adults and at-risk individuals over the age of 12. The traditional protein-based shot offers an alternative to its messenger RNA-based rivals from Pfizer/BioNTech and Moderna. Earlier this week, health secretary Robert F. Kennedy Jr., a long-time vaccine skeptic, fired all members of a U.S. Centers for Disease Control and Prevention panel of vaccine experts — a move public health experts said could undermine confidence in currently available shots.


Time of India
2 days ago
- Time of India
US health chief says he promised Senator Cassidy a vaccine panel member selection
Washington: U.S. Health and Human Services Secretary Robert F. Kennedy Jr. said on Thursday he promised to allow U.S. Senator Bill Cassidy to pick a candidate for a key panel of vaccine advisers . Kennedy, a long-time vaccine skeptic, named eight members on Wednesday to serve on the U.S. Centers for Disease Control and Prevention's Advisory Committee for Immunization Practices, including some who have advocated against vaccines. Kennedy earlier abruptly fired all 17 members who had been serving on the independent expert panel. "You had posted the criticism of my choice by Senator Cassidy and a claim that I had promised Senator Cassidy not to change the vaccine panels. That's not true," Kennedy said during an interview on Fox News' "The Story with Martha MacCallum." "What I told Senator Cassidy is that I would allow him to put one of his candidates on, which we're going to do," he said of the ACIP panel. Cassidy, a Republican doctor from Louisiana who had expressed wariness about Kennedy's anti-vaccine views before clearing the path for him to become the nation's top health official, serves as chairman of the U.S. Senate Committee on Health, Education, Labor, and Pensions. Cassidy explained his reversal at the time by saying he had received assurances Kennedy would protect existing vaccination programs. "If confirmed, he will maintain the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices without changes," Cassidy said in a Senate floor speech after receiving assurances from Kennedy. The senator expressed concern on Monday following the firings that the outgoing members would be replaced by vaccine skeptics and said he would speak to Kennedy to ensure that does not happen. At least half of the replacements Kennedy announced on Wednesday have a history of anti-vaccine advocacy. The American Medical Association called on Cassidy's committee to investigate Kennedy for the firings earlier this week, and on Thursday urged a reversal of the changes to the committee, which advises the CDC on who should get vaccines after they are approved by the Food and Drug Administration. Kennedy justified the firings by claiming the panel was rife with conflicts of interest, though he did not provide examples of any such conflicts for any individual adviser or say how that may have influenced specific recommendations.